Cardiac hypertrophy in diabetic spontaneously hypertensive rats: Role of angiotensin II?

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 6, 1997, Pages 445-448

  Black, M Jane ^a   Briscoe, Todd ^a   Bertram, John F ^a   Jackson, Bruce ^a   Johnston, Colin I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

angiotensin II; angiotensin converting enzyme inhibition; cardiac hypertrophy; diabetes; heart; hypertension; left ventricle; right ventricle; spontaneously hypertensive rat; stereology

Indexed keywords

ANGIOTENSIN; RAMIPRIL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HYPERTENSION; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT;

EID: 0030922093     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb01221.x     Document Type: Article

References (16)

1. Fuller J. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985; 7: 113-17.
2. Weber KT, Anversa P, Armstrong PW et al. Remodeling and reparation of the cardiovascular system. J. Am. Coll. Cardiol. 1992; 20: 3-16.
3. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog. Cardiovasc. Dis. 1985; 27: 255-70.
4. Van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic disease. Circulation 1990; 82: 848-55.
5. Shelling P, Fischer H, Ganten D. Angiotensin and cell growth: A link to cardiovascular hypertrophy? J. Hypertens. 1991; 9: 3-15.
6. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am. J. Hypertens. 1992; 5: 95-110.
7. Black MJ, Bertram JF, Johnston CI. Cardiac growth during high and low dose perindopril treatment in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1996; 23: 605-6.
8. Campbell DJ. Tissue renin-angiotensin system: Sites of angiotensin formation. J. Cardiovasc. Pharmacol. 1987; 10 (Suppl. 7): S1-8.
9. Sechi LA, Griffen CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 1994; 43: 1180-4.
10. Pijl AJ, van der Wal AC, Mathy MJ et al. Streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats: A pathophysiological model for the combined effects of hypertension and diabetes. J. Pharmacol. Toxicol. Methods 1994; 32: 225-33.
11. Bertram JF, Nurcombe V. Counting cells with the new stereology. Trends Cell Biol. 1992; 2: 177-80.
12. 1-receptor blockade. Am. J. Hypertens. 1996; 9: 895-901.
13. Given MB, Lowe RF, Gelvin CR, Sander GE, Giles TD. Preservation of left ventricular function and coronary flow by angiotensin I-converting enzyme inhibition in the hypertensive-diabetic dahl rat. Am. J. Hypertens. 1994; 7: 919-25.
14. Fukui M, Nakamura T, Ebihara I et al. Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic glomeruli. J. Lab. Clin. Med. 1994; 123: 763-8.
15. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 1995; 44: 895-9.
16. 1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: Involvement of endothelin. Eur. J. Pharmacol. 1995; 280: 11-17.